|
|
| | Hexanoic acid, 6-[[6-[(1-decylundecyl)oxy]-6-oxohexyl](2-hydroxyethyl)amino]-, undecyl ester Basic information |
| | Hexanoic acid, 6-[[6-[(1-decylundecyl)oxy]-6-oxohexyl](2-hydroxyethyl)amino]-, undecyl ester Chemical Properties |
| Boiling point | 744.5±50.0 °C(Predicted) | | density | 0.922±0.06 g/cm3(Predicted) | | pka | 14.67±0.10(Predicted) |
| | Hexanoic acid, 6-[[6-[(1-decylundecyl)oxy]-6-oxohexyl](2-hydroxyethyl)amino]-, undecyl ester Usage And Synthesis |
| Uses | LNP Lipid-1 (Method B) is a lipid compound. LNP Lipid-1 is involved in the synthesis of lipid nanoparticles compositions. LNP Lipid-1 has potential applications in the transport of biologically active substances such as small molecule agents, proteins, and nucleic acids[1][2]. | | References | [1] Benenato Kerry E, et al. Compounds and compositions for intracellular delivery of therapeutic agents. World Intellectual Property Organization. WO2020061367.
[2] Benenato K, et al. Polynucleotides encoding lipoprotein lipase for the treatment of hyperlipidemia. World Intellectual Property Organization. WO2017201333. |
| | Hexanoic acid, 6-[[6-[(1-decylundecyl)oxy]-6-oxohexyl](2-hydroxyethyl)amino]-, undecyl ester Preparation Products And Raw materials |
|